Close Menu

TriLink

TriLink hopes that these modifications will provide the same benefit as hot-start approaches for PCR; namely, a substantial improvement in specificity and performance compared to conventional LCR.

The grant will fund research by the firm to develop a Hot Start approach for Ligase Chain Reaction.

Product Watch: Dec 16, 2010

Premium

Agilent's SureSelect Target Enrichment System; TriLink Biotechnologies' CleanAmp 7-deaza-dGTP hot start mix.

The UK-based company said that its new product is the first-ever complete freeze-dried PCR kit, and can be transported and stored at ambient temperatures and used by relatively unskilled technicians, making it suitable for applications on a "global scale."

Biofortuna will use the dNTPs for a line of human leukocyte antigen diagnostic kits it is developing for the transplantation, blood grouping, disease identification, and pharmacogenetic markets.

Biofortuna is developing unique HLA diagnostic kits that will address the transplantation, blood grouping, disease identification, and pharmacogenetic markets, with the first product line targeting the sequence-specific primer transplantation market.

Under the terms of agreement, Affymetrix will use TriLink's oligonucleotides in several of its kits.

Affymetrix will use TriLink Biotechnologies' oligonucleotides in several of its kits.

The firm will use the funds to study chemically modified components as a means of enhancing ligation fidelity in a variety of applications.

TriLink will provide ETS Laboratories with its CleanAmp reagents for PCR assays testing for wine spoilers.

Pages

NPR says the explosion and fire earlier this week at a Russian lab that stores dangerous pathogens revives the question of whether such samples should be kept.

According to Wired, Nebula Genomics is providing a way for people to get their genomes sequenced anonymously.

A 26-year-old woman tells Cosmopolitan about learning her APOE status at a young age.

In Science journals this week: a functional genomic screen uncovers drug combination that increases KRAS inhibitor efficacy in aggressive lung cancer, and more.